Cholesterol-Cardiovascular Pathway

MBLI  provides reagents for quantifying PCSK9, which is secretory protein binding to receptor of low-density lipoprotein (LDL) to increase blood levels of LDL cholesterol through suppressing the uptake of LDL cholesterol to liver cells.

 

Cholesterol-Cardio_Pathway